Patent ID: 9629841
Date: 2017-04-25
CPC Classifications: A61K,A61P

Claim:
1. A pharmaceutical composition comprising: N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide (Compound A), or a pharmaceutically acceptable salt thereof, in an amount of from about 200 mg to about 300 mg on a free acid equivalent weight basis; and a bioavailability enhancing agent which is copovidone in an amount of from about 10% to about 25% by weight of the pharmaceutical composition, wherein the solubility of Compound A as measured by a biphasic dissolution test is at least 20 mcg per mL at 100 minutes.